288 related articles for article (PubMed ID: 32264626)
21. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
22. Functionalized mesoporous silica nanoparticles and biomedical applications.
Hoang Thi TT; Cao VD; Nguyen TNQ; Hoang DT; Ngo VC; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():631-656. PubMed ID: 30889738
[TBL] [Abstract][Full Text] [Related]
23. A facile strategy to fabricate a pH-responsive mesoporous silica nanoparticle end-capped with amphiphilic peptides by self-assembly.
Zhao F; Zhang C; Zhao C; Gao W; Fan X; Wu G
Colloids Surf B Biointerfaces; 2019 Jul; 179():352-362. PubMed ID: 30991215
[TBL] [Abstract][Full Text] [Related]
24. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
25. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
26. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
27. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
28. Global gene expression analysis of cellular death mechanisms induced by mesoporous silica nanoparticle-based drug delivery system.
Li X; He Q; Shi J
ACS Nano; 2014 Feb; 8(2):1309-20. PubMed ID: 24392791
[TBL] [Abstract][Full Text] [Related]
29. Smart Mesoporous Silica Nanoparticles for Protein Delivery.
Liu HJ; Xu P
Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 30986952
[TBL] [Abstract][Full Text] [Related]
30. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
[TBL] [Abstract][Full Text] [Related]
31. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.
Li ZY; Liu Y; Wang XQ; Liu LH; Hu JJ; Luo GF; Chen WH; Rong L; Zhang XZ
ACS Appl Mater Interfaces; 2013 Aug; 5(16):7995-8001. PubMed ID: 23869943
[TBL] [Abstract][Full Text] [Related]
32. Magnetic mesoporous silica nanoparticles end-capped with hydroxyapatite for pH-responsive drug release.
Zhao CX; Yu L; Middelberg APJ
J Mater Chem B; 2013 Oct; 1(37):4828-4833. PubMed ID: 32261164
[TBL] [Abstract][Full Text] [Related]
33. pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery.
Lin JT; Du JK; Yang YQ; Li L; Zhang DW; Liang CL; Wang J; Mei J; Wang GH
Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():478-484. PubMed ID: 28888000
[TBL] [Abstract][Full Text] [Related]
34. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
[No Abstract] [Full Text] [Related]
35. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
Sábio RM; Meneguin AB; Ribeiro TC; Silva RR; Chorilli M
Int J Pharm; 2019 Jun; 564():379-409. PubMed ID: 31028801
[TBL] [Abstract][Full Text] [Related]
36. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
37. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
38. Tumor microenvironment responsive drug delivery systems.
He Q; Chen J; Yan J; Cai S; Xiong H; Liu Y; Peng D; Mo M; Liu Z
Asian J Pharm Sci; 2020 Jul; 15(4):416-448. PubMed ID: 32952667
[TBL] [Abstract][Full Text] [Related]
39. Natural Biopolymers as Smart Coating Materials of Mesoporous Silica Nanoparticles for Drug Delivery.
Dumontel B; Conejo-Rodríguez V; Vallet-Regí M; Manzano M
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839771
[TBL] [Abstract][Full Text] [Related]
40. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility.
Feng W; Zhou X; He C; Qiu K; Nie W; Chen L; Wang H; Mo X; Zhang Y
J Mater Chem B; 2013 Nov; 1(43):5886-5898. PubMed ID: 32261055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
